TGA approves new severe asthma treatment Exdensur for Australians
A newly registered asthma treatment has been given the green light by the Therapeutic Goods of Australia (TGA),…
PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
Moitreyee Chatterjee-Kishore, PhD, MBA, Head of Oncology Development, Astellas“Building on the recent U.S. approval for cisplatin-ineligible patients living…
Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS
Geron Corporation Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target…